Agios Pharmaceuticals (AGIO) Gross Profit Growth (1y) (2018 - 2026)
Agios Pharmaceuticals (AGIO) Gross Profit Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.37% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 16.94% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 68.41% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.20 Bn | 1.46 Bn | 19.43 Mn | 154.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 154.25% |
| Dec 31, 2025 | 91.00% |
| Sep 30, 2025 | 36.91% |
| Jun 30, 2025 | 51.03% |
| Mar 31, 2025 | 1.04% |
| Dec 31, 2024 | 45.31% |
| Sep 30, 2024 | 20.91% |
| Jun 30, 2024 | 27.05% |
| Mar 31, 2024 | 49.59% |
| Dec 31, 2023 | 67.23% |
| Sep 30, 2023 | 125.61% |
| Jun 30, 2023 | 8.88% |
| Mar 31, 2023 | 925.35% |
| Dec 31, 2020 | 30.55% |
| Sep 30, 2020 | 32.92% |
| Jun 30, 2020 | 41.49% |
| Mar 31, 2020 | 189.58% |
| Dec 31, 2019 | 19.93% |
| Sep 30, 2019 | 76.73% |
| Jun 30, 2019 | -35.87% |